Skip to content

Therapeutic effect assessment of Cassia Seed of sickle senna (Cassia obtusifolia) on schizophrenia patients with obesity: a randomized, double blind, controlled trial

Therapeutic effect assessment of Cassia Seed of sickle senna (Cassia obtusifolia) on schizophrenia patients with obesity: a randomized, double blind, controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016703
Enrollment
Unknown
Registered
2018-06-19
Start date
2018-07-01
Completion date
Unknown
Last updated
2018-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity of Schizophrenia

Interventions

Study group:Cassia obtusifolia
controll group:Placebo

Sponsors

Calo Psychiatric Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients of Schizophrenia was diagnosed for at least 6 months, and antipsychotic medications were administered for at least 2 months; 2. BMI?24, and WC in female ?80 cm, in male ?90 cm; 3. Aged between 20 to 65 years (inclusive) male and female; 4. Conscious and stable condition can follow the study protocol; 5. After explaining in details of the purpose and process of the research, voluntarily participates in the agreement signed by the person or the legal representative; Note: BMI and waistline measurements were measured at 2 hours after breakfast, and the waistline was measured between the lower ribs and the gut Ridge (iliac crest).

Exclusion criteria

Exclusion criteria: 1. Suffering from major internal diseases such as cancer, liver and brain lesions, chronic renal failure, chronic obstructive pulmonary disease; 2. Pregnant women or lactating women; 3. Allergy for the Cassia Seed; 4. Value of liver function (SGOT or SGPT) is more than twice times normal value; 5. Value of renal function (BUN or creatinine) is greater than normal; 6. The person or legal representative does not sign consent.

Design outcomes

Primary

MeasureTime frame
Body Mass Index (BMI);waist circumference;

Countries

China

Contacts

Public ContactFor-Wey Lung
forwey@seed.net.tw+886 87981511

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026